Dashboard
Manage Tickers

CDTX Cidara Therapeutics, Inc.

Nasdaq cidara.com


$ 219.25 $ -0.20 (-0.09 %)    

Friday, 21-Nov-2025 15:53:51 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 590.67 nm (nm)
DIA $ 462.67 $ 5.05 (1.1 %)
SPY $ 659.16 nm (nm)
TLT $ 89.49 nm (nm)
GLD $ 373.41 nm (nm)
$ 219.35
$ 219.58
$ 219.22 x 128
$ 219.31 x 5
$ 219.00 - $ 219.85
$ 15.22 - $ 220.41
1,248,294
na
6.9B
$ 1.84
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 03-06-2025 01-01-1970 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-13-2024 06-30-2024 10-Q
7 05-15-2024 03-31-2024 10-Q
8 04-22-2024 12-31-2023 10-K
9 11-02-2023 09-30-2023 10-Q
10 08-03-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-23-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-11-2022 03-31-2022 10-Q
16 03-07-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-13-2021 03-31-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-13-2020 06-30-2020 10-Q
23 05-13-2020 03-31-2020 10-Q
24 03-04-2020 12-31-2019 10-K
25 11-08-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 02-28-2019 12-31-2018 10-K
29 11-08-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-10-2018 03-31-2018 10-Q
32 02-27-2018 12-31-2017 10-K
33 11-08-2017 09-30-2017 10-Q
34 08-09-2017 06-30-2017 10-Q
35 05-10-2017 03-31-2017 10-Q
36 03-15-2017 12-31-2016 10-K
37 11-10-2016 09-30-2016 10-Q
38 08-11-2016 06-30-2016 10-Q
39 05-12-2016 03-31-2016 10-Q
40 03-18-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

pfizers-new-mrna-flu-vaccine-outperforms-traditional-shot-against-predominant-strains
Pfizer's New mRNA Flu Vaccine Outperforms ...
11/21/2025 15:48:57

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side effects.

guggenheim-downgrades-cidara-therapeutics-to-neutral
Guggenheim Downgrades Cidara Therapeutics ...
11/18/2025 14:06:21

Guggenheim analyst Seamus Fernandez downgrades Cidara Therapeutics (NASDAQ:CDTX) from Buy to Neutral.

top-2-health-care-stocks-that-may-fall-off-a-cliff-this-month
Top 2 Health Care Stocks That May Fall Off...
11/17/2025 13:15:43

hc-wainwright--co-downgrades-cidara-therapeutics-to-neutral
HC Wainwright & Co. Downgrades Cidara Ther...
11/14/2025 19:34:04

HC Wainwright & Co. analyst Sara Nik downgrades Cidara Therapeutics (NASDAQ:CDTX) from Buy to Neutral.

needham-downgrades-cidara-therapeutics-to-hold
Needham Downgrades Cidara Therapeutics to ...
11/14/2025 18:52:51

Needham analyst Joseph Stringer downgrades Cidara Therapeutics (NASDAQ:CDTX) from Buy to Hold.

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
11/14/2025 17:06:24

gold-tumbles-over-2-cidara-therapeutics-shares-spike-higher
Gold Tumbles Over 2%; Cidara Therapeutics ...
11/14/2025 17:02:21

legence-cidara-therapeutics-avadel-pharmaceuticals-omeros-and-other-big-stocks-moving-higher-on-friday
Legence, Cidara Therapeutics, Avadel Pharm...
11/14/2025 14:54:48

nasdaq-dips-over-300-points-applied-materials-posts-upbeat-q4-earnings
Nasdaq Dips Over 300 Points; Applied Mater...
11/14/2025 14:42:17

merck-makes-big-bet-on-flu-protection-with-cidara-buyout
Merck Makes Big Bet On Flu Protection With...
11/14/2025 14:32:24

Merck (NYSE: MRK) to acquire Cidara (NASDAQ: CDTX) for $9.2 billion, diversifying its portfolio with CD388.

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
11/14/2025 12:06:17

Core News & Articles
Merck Bulks Up Respiratory Portfolio With ...
11/14/2025 11:48:05

Core News & Articles
Merck To Acquire Cidara Therapeutics For $...
11/14/2025 11:47:27

Core News & Articles
Financial Times Reported Merck Nears $9.2B...
11/14/2025 11:02:13

https://www.ft.com/content/743e1962-3dd1-4785-a20b-4b097e5514ae

why-rlx-technology-shares-are-trading-higher-by-6-here-are-20-stocks-moving-premarket
Why RLX Technology Shares Are Trading High...
11/14/2025 10:52:19

why-is-cidara-therapeutics-cdtx-stock-trending-overnight
Why Is Cidara Therapeutics (CDTX) Stock Tr...
11/14/2025 05:56:00

Cidara Therapeutics shares jumped over 42% in after-hours trading following a 13D filing and Phase 3 enrollment milestone.

rbc-capital-maintains-outperform-on-cidara-therapeutics-raises-price-target-to-145
RBC Capital Maintains Outperform on Cidara...
11/07/2025 18:48:28

RBC Capital analyst Brian Abrahams maintains Cidara Therapeutics (NASDAQ:CDTX) with a Outperform and raises the price target...

needham-maintains-buy-on-cidara-therapeutics-raises-price-target-to-135
Needham Maintains Buy on Cidara Therapeuti...
11/07/2025 10:12:55

Needham analyst Joseph Stringer maintains Cidara Therapeutics (NASDAQ:CDTX) with a Buy and raises the price target from $100...

update-cidara-therapeutics-q3-adj-eps-143-misses-135-estimate
UPDATE: Cidara Therapeutics Q3 Adj. EPS $(...
11/06/2025 22:55:34

Cidara Therapeutics (NASDAQ:CDTX) reported quarterly losses of $(1.43) per share which missed the analyst consensus estimate of...

cidara-therapeutics-q3-eps-310-misses-133-estimate
Cidara Therapeutics Q3 EPS $(3.10) Misses ...
11/06/2025 21:25:48

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION